While numerous antioxidant therapies directed at scavenging reactive species have failed to progress, it is thought that targeting the source of oxidative stress, through NADPH oxidase, could prove a more effective approach to reduce reperfusion injury after stroke. Here, FMO5 is linked to stroke disorder.